Browse by Authors and EditorsNumber of items: 4. 2018Sprigg, Nikola, Flaherty, Katie, Appleton, Jason P., Al-Shahi Salman, Rustam, Bereczki, Daniel, Beridze, M., Christensen, Hanne, Ciccone, Alfonso, Collins, Ronan, Czlonkowska, Anna, Dineen, Robert A., Duley, Lelia, Egea-Guerrero, Juan Jose, England, Timothy J., Krishnan, Kailash, Laska, Ann Charlotte, Law, Zhe Kang, Ozturk, Serefnur, Pocock, Stuart J., Roberts, Ian, Robinson, Thompson G., Roffe, Christine, Seiffge, David, Scutt, Polly, Thanabalan, Jegan, Werring, David, Whynes, David and Bath, Philip M. (2018) Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. The Lancet . ISSN 1474-547X 2017Salamanca-Balen, Natalia, Seymour, Jane, Caswell, Glenys, Whynes, David and Tod, Angela (2017) The costs, resource use, and cost-effectiveness of Clinical Nurse Specialist (CNSs) led interventions for patients with palliative care needs: a systematic review of international evidence. Palliative Medicine . pp. 1-19. ISSN 1477-030X 2016Sprigg, Nikola, Robson, Katie, Bath, Philip M.W., Dineen, Robert A., Roberts, Ian, Robinson, Tom, Roffe, Christine, Werring, David, Al-Shahi Salman, Rustam, Pocock, Stuart J., Duley, Lelia, England, Timothy J., Whynes, David, Ciccone, Alfonso, Laska, Ann Charlotte, Christensen, Hanne, Ozturk, Serefnur, Collins, Ronan, Bereczki, Daniel, Egea-Guerrero, Juan Jose, Law, Zhe Kang, Czlonkowska, Anna, Seiffge, David and Beredzie, Maia (2016) Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: protocol for a randomized, placebo-controlled trial. International Journal of Stroke, 11 (6). pp. 683-694. ISSN 1747-4949 2015Lim, Wei Shen, Brittain, Clare, Duley, Lelia, Edwards, Sheila, Gordon, Stephen, Montgomery, Alan, Nguyen-Van-Tam, Jonathan, Read, Robert, Whitham, Diane, Whynes, David, Woodhead, Mark and Wootton, Dan (2015) Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation. Health Technology Assessment, 19 (16). pp. 1-78. ISSN 1366-5278 |